Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 781 of 1,261
  1. US 8895740

    Pyrazolopyrazine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  2. US 8895723

    Methods of preparing substituted nucleotide analogs

    Vertex Pharmaceuticals Incorporated · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  3. US 8895591

    Tricyclic compound and pharmaceutical use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  4. FR 3005577

    TRAITEMENT DE L'INCONFORT BUCCAL

    BIOCODEX [FR] · Granted Nov 21, 2014 · Expires Nov 16, 2034

    granted
  5. AU 2013258031

    Parenteral esmolol formulation

    AOP ORPHAN PHARMACEUTICALS AG [AT] · Granted Nov 20, 2014 · Expires Nov 15, 2034

    granted
  6. US 8889743

    Inhibition of filovirus entry into cells and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  7. US 8889831

    Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypeptide conjugate

    Nektar Therapeutics · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  8. US 8889875

    Pyridyl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  9. US 8889625

    Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia

    Northwestern University · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  10. US 8889213

    Processes for coating a carrier with microparticles

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  11. US 8889156

    Calcium-binding agents induce hair growth and/or nail growth

    The Regents of the University of California · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  12. US 8889191

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  13. US 8889138

    Anti-ADDL antibodies and uses thereof

    Northwestern University · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  14. US 8889623

    Immunostimulatory nanoparticles and related compositions, methods and systems

    The Board of Regents of the University of Texas System · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  15. US 8889140

    Compositions and methods for tissue repair

    The Regents of the University of California · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  16. US 8889627

    Treatment of multiple sclerosis with combination of laquinimod and fingolimod

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  17. US 8889425

    Means and methods for the determination of camp in vitro and in vivo

    Bayerische Julius-Maximilians-Universität Würzburg · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  18. US 8889635

    Dendrimer conjugates

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  19. US 8889638

    Stimulus-triggered prodrugs

    The Regents of the University of California · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  20. US 8888902

    Portable oxygen enrichment device and method of use

    SEPARATION DESIGN GROUP LLC · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  21. US 8889661

    Treatment of lupus nephritis using laquinimod

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  22. US 8889644

    GNAQ targeted dsRNA compositions and methods for inhibiting expression

    Alnylam Pharmaceuticals, Inc. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  23. US 8889133

    Methods of treating diabetes with Dll4 antagonists

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  24. US 8889121

    Bacterium comprising a regulated rfaH nucleic acid

    The Arizona Board of Regents for an on Behalf of Arizona State University · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.